Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti
Kutahya, Turkey
University hospital in Kütahya
İstiklal, Okmeydanı Cd., 43040 Merkez/Kütahya
About Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Clinical Trials at Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti
During the past decade, Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti
According to Clinical.Site data, the most researched conditions in "Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti" are
"Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti" in a lesser frequency.
Clinical Trials Intervention Types at Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti
Most popular intervention types in "Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti
The vast majority of trials in "Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti" are
2 trials for "All" genders.
Clinical Trials Status at Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti
Currently, there are NaN active trials in "Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kutahya Saglik Bilimleri Uni. Evliya Celebi Egitim ve Arasti, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".